- 1. BCAA
- [Encoded by human RBBP1L1 Gene, 803-amino acid 91 kD RBP1-Like Protein is similar to RBP1, containing a Tudor domain and an ARID DNA binding domain. Different protein isoforms are thought to exist, but all have not been fully determined. Variant 2 encodes a shortened isoform 2 that lacks an internal protein fragment. (from SWISS-PROT, LocusLink, and NCI) ( NCI )] (UMLS (NCI) C1337094) BCAA Protein;
BRCAA1 Protein;
Breast Cancer-Associated Antigen BRCAA1;
Breast Carcinoma-Associated Antigen BCAA;
KIAA0117 Protein;
Rb-Binding Protein Homolog;
RBBP1L1 Protein;
RBP1-Like Protein;
Retinoblastoma-Binding Protein 1-Like 1 =Amino Acid, Peptide, or Protein; Biologically Active Substance | - 6. BCAS1
- [This gene plays a role in tumorigenesis. ( NCI )] (UMLS (NCI) C1332387) BCAS1 Gene;
Breast Carcinoma Amplified Sequence 1 Gene =Gene or Genome ;
|
- 2. BCAP
- (UMLS (NCI) C1510468) BLEO/CDDP/CTX/DOX;
Bleomycin/Cisplatin/Cyclophosphamide/Doxorubicin =Therapeutic or Preventive Procedure ;
| - 7. BCAS2
- [This gene plays a role in transcriptional regulation. ( NCI )] (UMLS (NCI) C1332388) BCAS2 Gene;
Breast Carcinoma Amplified Sequence 2 Gene =Gene or Genome ;
◊ [Encoded by human BCAS2 Gene, the ubiquitous 225-amino acid DAM1 Protein contains a central putative N-glycosylation site and multiple N-terminal putative phosphorylation sites. A sequence identical to DAM1 is seen in Putative Spliceosome-Associated Protein SPF27. (from OMIM, and NCI) ( NCI )] (UMLS (NCI) C1332620) BCAS2 Protein; Breast Carcinoma Amplified Sequence 2; DAM1 Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 3. BCAR1
- [This gene plays a role in signal transduction and is involved in cell adhesion, migration and proliferation. ( NCI )] (UMLS (NCI) C1366459) BCAR1 Gene;
Breast Cancer Anti-Estrogen Resistance 1 Gene =Gene or Genome ◊ [Encoded by human BCAR1 Gene, conserved ubiquitous 870-amino acid 116 kD cytoplasmic p130CAS (CAS Family) is an adaptor molecule: Ser-region, NH-SH3, central YXXP motif SH2-binding site substrate domain, SRC SH3-binding site COOH Pro-rich binding region, and C-terminal HLH. SH3 localizes CAS to focal adhesions; interacts with FAK1 P-rich region. FAK1 phosphorylates CAS YDYVHL motif. SRCs phosphorylate CAS. CAS SH2-binding sites may bind CRK, NCK, and ABL. CAS HLH may dimerize CASL. CAS Ser region promotes serum response. CAS moves to focal adhesions upon integrin triggered Y-phosphorylation. CAS complexes with CRKL and LYN. CAS functions in cardiovascular development, actin assembly, cell migration, and growth. Over expression confers breast cancer anti-estrogen resistance. (from SWISS-PROT, OMIM, and NCI) ( NCI )] (UMLS (NCI) C1451357) BCAR1 Protein; Breast Cancer Anti-Estrogen Resistance 1 Protein; CAS; CRKAS; CRK-Associated Substrate; p130CAS Amino Acid, Peptide, or Protein; Biologically Active Substance ; | - 8. BCAS3
- [This gene plays a role in transcriptional regulation. ( NCI )] (UMLS (NCI) C1332389) BCAS3 Gene;
Breast Carcinoma Amplified Sequence 3 Gene =Gene or Genome ;
◊ [Encoded by human BCAS3 Gene, 913-amino acid 99.6 kD BCAS3 Protein has an unknown function. (from SWISS-PROT, LocusLink, and NCI) ( NCI )] (UMLS (NCI) C1332621) BCAS3 Protein; Breast Carcinoma Amplified Sequence 3; Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 4. BCAR2
- [This gene is involved in tumorigenesis. ( NCI )] (UMLS (NCI) C1332385) BCAR2 Gene;
Breast Cancer Anti-Estrogen Resistance 2 Gene =Gene or Genome ;
◊ [Encoded by human BCAR2 Gene, Breast Cancer Anti-Estrogen Resistance 2 Protein is similar to gamma-butyrobetaine 2-oxoglutarate dioxygenase (C. elegans, Drosophila) and likely responsible for development of an anti-estrogen-resistant phenotype. (from Int J Cancer. 1997; 72:700, LocusLink, GeneCard, and NCI) ( NCI )] (UMLS (NCI) C1332615) BCAR2 Protein; Breast Cancer Anti-Estrogen Resistance 2 Protein; Amino Acid, Peptide, or Protein; Biologically Active Substance | - 9. BCAS4
- [This gene plays a role in transcriptional regulation. ( NCI )] (UMLS (NCI) C1332390) BCAS4 Gene;
Breast Carcinoma Amplified Sequence 4 Gene =Gene or Genome ;
◊ [Encoded by human BCAS4 Gene, 211-amino acid 22.8 kD BCAS4 Protein has an unknown function but high similarity to a region of MAP4K1 and similarity to metalloendopeptidase (Drosophila). BCAS4 is expressed in brain, heart, liver, pancreas, prostate, kidney, and lung. (from SWISS-PROT, LocusLink, and NCI) ( NCI )] (UMLS (NCI) C1332622) BCAS4 Protein; Breast Carcinoma Amplified Sequence 4; Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 5. BCAR3
- [Encoded by human BCAR3 Gene, the 92.6 kD 825-amino acid BCAR3 Protein contains a putative SH2 domain, a hallmark of tyrosine kinase signaling molecules, and sequences homologous to CDC48 (Yeast). Abundant expression is seen in heart, placenta, skeletal muscle, spleen, prostate, testis, ovary, small intestine, colon, fetal kidney, and several cancer cell lines, but not in nonmalignant breast tissue. NSP2 induces anti-estrogen resistance in estrogen-dependent breast tumors. (from SWISS-PROT, OMIM, and NCI) ( NCI )] (UMLS (NCI) C1309026) Breast Cancer Anti-Estrogen Resistance 3;
Breast Cancer Anti-Estrogen Resistance 3 Protein;
Novel SH2-Containing Protein 2 =Amino Acid, Peptide, or Protein; Biologically Active Substance ◊ [This gene plays a role in cell cycle regulation and tumorigenesis. ( NCI )] (UMLS (NCI) C1332386) BCAR3 Gene; Breast Cancer Anti-Estrogen Resistance 3 Gene Gene or Genome ; | |
home
